Skip to content

Effect of Dexmedetomidine Dosage on Postoperative Delirium in Geriatric Orthopedic Surgery

Dose-Effect Relationship of Dexmedetomidine on Delirium and Cognitive Function After Lower Limb Orthopedic Surgeries for Elderly Patients

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07443085
Enrollment
75
Registered
2026-03-02
Start date
2026-02-26
Completion date
2026-08-24
Last updated
2026-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium - Postoperative

Brief summary

This study evaluates the dose-response relationship of Dexmedetomidine (DEX) in reducing the incidence and severity of postoperative delirium (POD) and postoperative cognitive dysfunction (POCD) in elderly patients. The study compares different doses of DEX against a fentanyl control group in patients undergoing major lower limb orthopedic surgery under general anesthesia to determine the optimal dosage for cognitive protection.

Interventions

DRUGDexmedetomidine (Low dose)

Patients receive a specific low-dose intravenous infusion of Dexmedetomidine during major lower limb orthopedic surgery under opioid-based general anesthesia. The intervention aims to evaluate the dose-response relationship regarding its neuroprotective effects on postoperative delirium (POD).

DRUGDexmedetomidine (High dose)

Patients receive a higher-dose intravenous infusion of Dexmedetomidine during the surgical procedure. This arm is designed to determine if higher concentrations of DEX provide a more significant reduction in the incidence and severity of postoperative delirium and cognitive dysfunction compared to the lower dose.

DRUGFentanyl

Patients in this group receive standard opioid-based general anesthesia using fentanyl without the addition of Dexmedetomidine. This group serves as the baseline to compare the efficacy of DEX in preventing cognitive decline.

Sponsors

Benha University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
55 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Elderly surgical patients. * ASA physical status grade II-III. * Planned major lower limb orthopedic surgery.

Exclusion criteria

* pre-existing dementia or drug allergies

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Postoperative Delirium (POD)48 hours post-surgeryThe percentage of participants diagnosed with delirium within the first 48 hours after surgery. Diagnosis is defined by the Confusion Assessment Method (CAM) algorithm, requiring the presence of acute onset/fluctuating course and inattention, plus either disorganized thinking or altered level of consciousness. Unit of Measure: Percentage of participants

Secondary

MeasureTime frameDescription
Severity of Postoperative Cognitive Dysfunction (POCD)1st and 4th weeks post-surgeryAssessment of cognitive decline using the Mini-Mental State Examination (MMSE) scores compared to baseline. Unit: Score on a scale of 0 to 30
Postoperative Sedation Level24 hours post-surgeryEvaluation of patient sedation levels using the Ramsey Sedation Score (RSS). Unit: Scale Score (1-6)

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 26, 2026